Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy

NCT00540384 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Solid Tumors

Interventions

DRUG: Placebo
DRUG: Novel Erythropoiesis Stimulating Protein (NESP) (darbepoetin alfa)

Sponsor

Amgen